{"id":408504,"date":"2021-01-05T08:33:27","date_gmt":"2021-01-05T13:33:27","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=408504"},"modified":"2021-01-05T08:33:27","modified_gmt":"2021-01-05T13:33:27","slug":"cv-sciences-inc-announces-launch-of-procbd-product-line","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/","title":{"rendered":"CV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line"},"content":{"rendered":"

\nClinical Strength ProCBD\u2122 is Supported by Clinical Research and Available Exclusively Through Health Practitioners
\n<\/h2>\n
\n

SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) — CV Sciences, Inc.<\/a> (OTCQB:CVSI) (the \u201cCompany\u201d, \u201cCV Sciences\u201d, \u201cour\u201d, \u201cus\u201d or \u201cwe\u201d), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced the launch of ProCBD\u2122, a full product line of clinical strength CBD products available exclusively through health practitioners.<\/p>\n

Clinical strength ProCBD\u2122 products were created with the CV Sciences Medical Advisory Board specifically to meet patient needs and to fit seamlessly with existing care plans. ProCBD\u2122 is the only CBD supported by published investigations, randomized controlled trial, and post marketing safety review.<\/p>\n

Formulated with CV Sciences\u2019 decarboxylated and distilled hemp extract for concentrated CBD levels that are best used under a specialist\u2019s care, ProCBD\u2122 is available in Roll-On, Liquids and Softgels. The ProCBD\u2122 product line is non-GMO, gluten free, plant-based and vegan friendly.<\/p>\n

\u201cAs the only clinical strength CBD on the market supported by multiple research studies, we believe ProCBD\u2122 has tremendous potential in the professional healthcare channel,\u201d said Joseph Dowling, Chief Executive Officer of CV Sciences. \u201cThe use of alternative medicine is becoming increasingly prevalent as consumer preferences continue to shift toward natural, plant-based remedies for a range of medical conditions. We are excited to launch ProCBD\u2122 and partner with medical professionals seeking science-based, natural alternatives to provide to their patients.\u201d<\/p>\n

\n About CV Sciences, Inc.<\/strong>\n <\/p>\n

CV, or Curriculum Vitae, is Latin for \u201ccourse of life\u201d, and science is the pursuit of truth. CV Sciences: our name is our mission — improving quality of life through nature and science.<\/p>\n

CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based dietary supplements and CBD products to a range of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics. The Company\u2019s PlusCBD\u2122 products are sold at more than 6,200 retail locations throughout the U.S. and it is the top-selling brand of hemp-derived CBD on the market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. \u00a0CV Sciences follows all guidelines for Good Manufacturing Practices (GMP) and the Company\u2019s products are processed, produced, and tested throughout the manufacturing process to confirm strict compliance with company standards and specifications.\u00a0 With a commitment to science, PlusCBD\u2122 product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov<\/u><\/a>.\u00a0 PlusCBD\u2122 was the first hemp CBD supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. CV Sciences, Inc. has primary offices and facilities in San Diego, California. \u00a0Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com<\/u><\/a>.<\/p>\n

\n FORWARD-LOOKING DISCLAIMER<\/em>\n <\/p>\n

\n This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and\/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.<\/em>\n <\/p>\n

\n CONTACT INFORMATION<\/strong>:
Investor Contact:
ICR
Scott Van Winkle
617-956-6736
scott.vanwinkle@icrinc.com<\/a><\/p>\n

Media Contact:
ICR
Cory Ziskind
646-277-1232
cory.ziskind@icrinc.com<\/a><\/p>\n

A photo accompanying this announcement is available at https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/2e055ef7-e738-48a7-90a3-dfa536005a6a<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Clinical Strength ProCBD\u2122 is Supported by Clinical Research and Available Exclusively Through Health Practitioners SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the \u201cCompany\u201d, \u201cCV Sciences\u201d, \u201cour\u201d, \u201cus\u201d or \u201cwe\u201d), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced the launch of ProCBD\u2122, a full product line of clinical strength CBD products available exclusively through health practitioners. Clinical strength ProCBD\u2122 products were created with the CV Sciences Medical Advisory Board specifically to meet patient needs and to fit seamlessly with existing care plans. ProCBD\u2122 is the only CBD supported by published investigations, randomized controlled trial, and post marketing safety review. Formulated with CV Sciences\u2019 decarboxylated and distilled hemp extract for concentrated CBD levels that … <\/p>\n

Continue reading “CV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-408504","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Clinical Strength ProCBD\u2122 is Supported by Clinical Research and Available Exclusively Through Health Practitioners SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the \u201cCompany\u201d, \u201cCV Sciences\u201d, \u201cour\u201d, \u201cus\u201d or \u201cwe\u201d), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced the launch of ProCBD\u2122, a full product line of clinical strength CBD products available exclusively through health practitioners. Clinical strength ProCBD\u2122 products were created with the CV Sciences Medical Advisory Board specifically to meet patient needs and to fit seamlessly with existing care plans. ProCBD\u2122 is the only CBD supported by published investigations, randomized controlled trial, and post marketing safety review. Formulated with CV Sciences\u2019 decarboxylated and distilled hemp extract for concentrated CBD levels that … Continue reading "CV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-05T13:33:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDIxNSMzOTAzNjkxIzIwOTE5ODg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cv-sciences-inc-announces-launch-of-procbd-product-line\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cv-sciences-inc-announces-launch-of-procbd-product-line\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line\",\"datePublished\":\"2021-01-05T13:33:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cv-sciences-inc-announces-launch-of-procbd-product-line\\\/\"},\"wordCount\":599,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cv-sciences-inc-announces-launch-of-procbd-product-line\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDIxNSMzOTAzNjkxIzIwOTE5ODg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cv-sciences-inc-announces-launch-of-procbd-product-line\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cv-sciences-inc-announces-launch-of-procbd-product-line\\\/\",\"name\":\"CV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cv-sciences-inc-announces-launch-of-procbd-product-line\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cv-sciences-inc-announces-launch-of-procbd-product-line\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDIxNSMzOTAzNjkxIzIwOTE5ODg=\",\"datePublished\":\"2021-01-05T13:33:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cv-sciences-inc-announces-launch-of-procbd-product-line\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cv-sciences-inc-announces-launch-of-procbd-product-line\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cv-sciences-inc-announces-launch-of-procbd-product-line\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDIxNSMzOTAzNjkxIzIwOTE5ODg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDIxNSMzOTAzNjkxIzIwOTE5ODg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cv-sciences-inc-announces-launch-of-procbd-product-line\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/","og_locale":"en_US","og_type":"article","og_title":"CV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line - Market Newsdesk","og_description":"Clinical Strength ProCBD\u2122 is Supported by Clinical Research and Available Exclusively Through Health Practitioners SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the \u201cCompany\u201d, \u201cCV Sciences\u201d, \u201cour\u201d, \u201cus\u201d or \u201cwe\u201d), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced the launch of ProCBD\u2122, a full product line of clinical strength CBD products available exclusively through health practitioners. Clinical strength ProCBD\u2122 products were created with the CV Sciences Medical Advisory Board specifically to meet patient needs and to fit seamlessly with existing care plans. ProCBD\u2122 is the only CBD supported by published investigations, randomized controlled trial, and post marketing safety review. Formulated with CV Sciences\u2019 decarboxylated and distilled hemp extract for concentrated CBD levels that … Continue reading \"CV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-05T13:33:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDIxNSMzOTAzNjkxIzIwOTE5ODg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line","datePublished":"2021-01-05T13:33:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/"},"wordCount":599,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDIxNSMzOTAzNjkxIzIwOTE5ODg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/","name":"CV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDIxNSMzOTAzNjkxIzIwOTE5ODg=","datePublished":"2021-01-05T13:33:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDIxNSMzOTAzNjkxIzIwOTE5ODg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDIxNSMzOTAzNjkxIzIwOTE5ODg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cv-sciences-inc-announces-launch-of-procbd-product-line\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CV Sciences, Inc. Announces Launch of ProCBD\u2122 Product Line"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=408504"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408504\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=408504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=408504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=408504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}